Mark Vergnano, a director at $JCI, bought 7,665 shares of the company on 02-05-2026 for an estimated $1,011,320. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 25.6%. Following this trade, they now own 37,602 shares of this class of $JCI stock.
$JCI Insider Trading Activity
$JCI insiders have traded $JCI stock on the open market 6 times in the past 6 months. Of those trades, 1 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $JCI stock by insiders over the last 6 months:
- LEI ZHANG SCHLITZ (VP & Pres, Global Products) has made 0 purchases and 2 sales selling 42,531 shares for an estimated $4,907,224.
- JOHN DONOFRIO (Exec VP & General Counsel) sold 21,595 shares for an estimated $2,505,020
- MARK VERGNANO purchased 7,665 shares for an estimated $1,011,320
- DANIEL C MCCONEGHY (VP Chief Accounting & Tax Ofcr) sold 5,917 shares for an estimated $625,604
- NATHAN D MANNING (VP and President, Americas) sold 1,422 shares for an estimated $149,395
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$JCI Hedge Fund Activity
We have seen 661 institutional investors add shares of $JCI stock to their portfolio, and 607 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 6,241,705 shares (+78.3%) to their portfolio in Q3 2025, for an estimated $686,275,464
- VIKING GLOBAL INVESTORS LP added 5,346,130 shares (+368.5%) to their portfolio in Q3 2025, for an estimated $587,806,993
- FMR LLC removed 4,792,551 shares (-47.9%) from their portfolio in Q3 2025, for an estimated $526,940,982
- BANK OF NEW YORK MELLON CORP removed 3,986,488 shares (-49.5%) from their portfolio in Q3 2025, for an estimated $438,314,355
- PITCAIRN CO removed 3,636,741 shares (-99.9%) from their portfolio in Q3 2025, for an estimated $399,859,672
- VANGUARD GROUP INC removed 3,250,013 shares (-4.7%) from their portfolio in Q4 2025, for an estimated $389,189,056
- DODGE & COX removed 2,712,122 shares (-4.1%) from their portfolio in Q3 2025, for an estimated $298,197,813
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$JCI Congressional Stock Trading
Members of Congress have traded $JCI stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $JCI stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIA LETLOW sold up to $15,000 on 10/02.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 08/19.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$JCI Analyst Ratings
Wall Street analysts have issued reports on $JCI in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Buy" rating on 11/07/2025
- Argus Research issued a "Buy" rating on 11/07/2025
- JP Morgan issued a "Overweight" rating on 10/15/2025
- Morgan Stanley issued a "Overweight" rating on 08/21/2025
To track analyst ratings and price targets for $JCI, check out Quiver Quantitative's $JCI forecast page.
$JCI Price Targets
Multiple analysts have issued price targets for $JCI recently. We have seen 9 analysts offer price targets for $JCI in the last 6 months, with a median target of $139.0.
Here are some recent targets:
- Joe O'Dea from Wells Fargo set a target price of $145.0 on 02/05/2026
- Deane Dray from RBC Capital set a target price of $140.0 on 02/05/2026
- Andrew Kaplowitz from Citigroup set a target price of $139.0 on 02/05/2026
- Brett Linzey from Mizuho set a target price of $130.0 on 02/05/2026
- Julian Mitchell from Barclays set a target price of $136.0 on 02/05/2026
- Chris Snyder from Morgan Stanley set a target price of $130.0 on 01/13/2026
- Joe Ritchie from Goldman Sachs set a target price of $142.0 on 11/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.